Publications : MDCG

MDCG 2020-12 : Guidance on transitional provisions for consultations of authorities on devices incorporating a substance which may be considered a medicinal product and which has action ancillary to that of the device, as well as on devices manufactured using TSE susceptible animal tissues – June 2020

  Theme Specific additional procedures Target audience Notified Bodies, Manufacturers Products concerned ·       Devices containing a substance which may be considered a medicinal product and which has action ancillary to that of the device ·       Devices...

read more

MDCG 2020-11 – Guidance on the renewal of designation and monitoring of notified bodies under Directives 90/385/EEC and 93/42/EEC to be performed in accordance with Commission Implementing Regulation (EU) 2020/666 amending Commission Implementing Regulation – April 2020

Theme Designation and monitoring of Notified Bodies (NB) Target audience Authority responsible for Notified Bodies Products concerned MD, AIMD Documents mentioned Commission Implementing Regulation (EU) 2020/666 of 18 May 2020 amending Implementing Regulation (EU) No...

read more

Archives

Contact us

Le Forum Bat B
515 Avenue de La Tramontane
13600 La Ciotat
FRANCE

+33 (0)4 42 01 60 29
Write us

Select your topic

Corporate

UDI System

Innovation

Quality

Digital health

Regulation

Electrical devices

PMS / PMCF

Clinical evaluation

Process / Production

Risk management